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a b s t r a c t 
Injuries affecting load bearing tendon tissues are a significant clinical burden and efficient treatments are 
still unmet. Tackling tendon regeneration, tissue engineering strategies aim to develop functional substi- 
tutes that recreate native tendon milieu. Tendon mimetic scaffolds capable of remote magnetic respon- 
siveness and functionalized magnetic nanoparticles (MNPs) targeting cellular mechanosensitive receptors 
are potential instructive tools to mediate mechanotransduction in guiding tenogenic responses. In this 
work, we combine magnetically responsive scaffolds and targeted Activin A type II receptor in human 
adipose stem cells (hASCs), under alternating magnetic field (AMF), to synergistically facilitate exter- 
nal control over signal transduction. The combination of remote triggering TGF- β/Smad2/3 using MNPs 
tagged hASCs, through magnetically actuated scaffolds, stimulates overall expression of tendon related 
genes and the deposition of tendon related proteins, in comparison to non-stimulated conditions. More- 
over, the phosphorylation of Smad2/3 proteins and their nuclear co-localization was also more evident. 
Overall, biophysical stimuli resulting from magnetic scaffolds and magnetically triggered cells under AMF 
stimulation modulate the mechanosensing response of hASCs towards tenogenesis, holding therapeutic 
promise. 
Statement of Significance 
The concept of magnetically-assisted tissue engineering may assist the development of innovative solu- 
tions to treat tendon disorders upon remote control of biological processes as cell migration or differenti- 
ation. Herein, we originally combine a fibrous aligned superparamagnetic scaffold, based on a biodegrad- 
able polymeric blend of starch and poly- ɛ -caprolactone incorporating magnetic nanoparticles (MNPs), and 
human adipose stem cells (hASCs) labelled with MNPs functionalized with anti-activin receptor type IIA 
(ActRIIA). Constructs were stimulated using alternating magnetic field (AMF), to activate the ActRIIA and 
subsequent induction of TGF- β signaling, through Smad2/3 phosphorylation cascade, enhancing the ex- 
pression of tendon-related markers. Altogether, these findings contribute with powerful bio-magnetic ap- 
proaches to activate key tenogenic pathways, envisioning future translation of magnetic biomaterials into 
regenerative platforms for tendon repair. 
© 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. ∗ Corresponding authors. 
E-mail addresses: ana.goncalves@i3bs.uminho.pt (A.I. Gonçalves),
megomes@i3bs.uminho.pt (M.E. Gomes). 
https://doi.org/10.1016/j.actbio.2020.07.009 
1742-7061/© 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved. 























































































Tendons are connective tissues which main function is the
ransmission of forces between muscles and bones, enabling body
otion [1] . Many factors are likely to be involved in the onset of
endon injuries. Intrinsic factors include age, gender, anatomical
ariants, body weight, systemic disease, and genetic predisposi-
ion. Extrinsic factors include sporting activities, physical loading,
ccupation, and environmental conditions [2] . As a consequence
f injury, tendon undergoes a repair process instead of complete
egeneration which leads to the formation of a scar tissue lim-
ting tendon gliding and motion amplitude, with a high risk of
e-injury and/or associated pain [3] . Currently, classical treatments
ncluding oral administration of anti-inflammatory drugs and/or
hysical rehabilitation and surgical interventions fail in inducing
 regenerative process and restoring the original functionality of
he tissue [4] . In this context, tissue engineering (TE) emerges as
 promising superior option for the development of competent
ioartificial substitutes encouraging the regeneration of the dam-
ged tissue. Moreover, magnetically-assisted strategies to remotely
eliver stimuli directly to cells is a promising approach in tissue
ngineering. Magnetic actuation concomitantly combined with
agnetic responsive materials represent tools with bioinstruc-
ive action in vitro but also upon implantation for remote cell
echanotransduction stimulation. 
Previous studies suggest that the actuation of magnetic
anoparticles (MNPs) in response to an external magnetic force
ithin a biomaterial substrate, causes its local deformation [5] ,
hich is able to activate/promote cells mechanotransduction
echanisms that will ultimately drive cellular responses [6 , 7] .
trategies applying magnetic stimuli combined with magnetic re-
ponsive scaffolds have shown positive outcomes in bone [8] , car-
iac [9] , and vascular [10] TE. Our group has recently reported
n magnetic responsive fibrous scaffolds for tendon TE, suggesting
ctivation of YAP/TAZ signaling in response to magnetic stimulus
11] . These strategies may have an important role in tenogenic dif-
erentiation of stem cells [11–14] and/or in the modulation of the
nflammatory response [15 , 16] , envisioning improved repair out-
omes. Signaling cascades act as transducers of mechanical forces
nto downstream mechanosensory molecules. MNPs targeting cell
embrane receptors or ion channels, by magnetic mechano activa-
ion technology, have been explored as a powerful instructive toolig. 1. Schematic representation of transcriptional regulation of tendon specific markers 
hrough alternating magnetic field (AMF). The mechanism of TGF- β signaling involves t
ype IIA (ActRIIA), using anti-ActRIIA functionalized MNPs, phosphorylates/activates the 
ubstrate Smad2/3. Upon activation through remote magnetic stimulation, the phosphory
nd subsequently inducing tenogenic transcriptional responses. o actuate signaling pathways in human mesenchymal stem cells
or TE approaches [13 , 17–19] . Transforming growth factor (TGF)- β
ignaling, transduced by Smad2/3 cascade, has been most associ-
ted to tendon formation, differentiation, and homeostasis [20 , 21] ,
ighlighting its interest as a potential molecular target for mag-
etic actuated strategies. On the other hand, activin receptor type
IA (ActRIIA) has been suggested to be involved in the regulatory
athway of the mechanosensitive gene Tenomodulin [13 , 22–24] ,
nown as a tendon lineage marker. Upon activation of this recep-
or, an intracellular signaling through phosphorylation of Smad2/3
s initiated [25] . 
In a previous work of our group, we reported that tar-
eted ActRIIA in human adipose stem cells (hASCs), using MNPs
nd magnetic stimulation, induced tenogenic transcriptional re-
ponses, through TGF- β/Smad2/3 signaling pathway [13] . More-
ver, 3D-printed polymeric composites incorporating MNPs within
ts aligned fiber structure were designed by us showing improved
iological performance in comparison with non-magnetic counter-
arts [12] . 
Herein we hypothesized that combining the two approaches
ay potentiate the tenogenic differentiation of hASCs through
agnetically assisted tissue engineering tools with magnetic bio-
aterials serving as mediators of mechanotransduction. Specifi-
ally, we propose to assess the synergistic effect of hASCs labelled
ith anti-ActRIIA functionalized MNPs, seeded onto magnetic scaf-
olds, and remotely actuated by external magnetic field. The re-
ote actuation of an alternating magnetic field (AMF) was pro-
ided by a custom-designed solenoid device, to stimulate cells
aden on the magnetic scaffolds and assist the regulation of ten-
on related markers to drive tenogenesis ( Fig. 1 ). 
. Materials and methods 
.1. Fabrication and characterization of magnetic scaffolds 
.1.1. Fabrication of magnetic scaffolds 
The aligned fibrous magnetic scaffolds (magSPCL) were pro-
uced by 3D-printing using a biodegradable polymeric blend
f starch and polycaprolactone (SPCL, 30/70%, Novamont) incor-
orating commercially available iron oxide magnetic nanoparti-
les (MNPs, 45-00-252, Micromod) in a ratio of 0.018:1 (w/w)
NPs:SPCL [12] . For this purpose, a SPCL and iron oxide MNPsby activation of the TGF- β/Smad2/3 signaling pathway in 3D magnetic constructs 
wo types of serine/threonine kinase receptors to signal. Targeted Activin receptor 
type I receptor kinase (ALK4/ALK5) providing a binding site for the downstream 
lation of Smad2/3 is induced allowing translocation of the complex to the nucleus 










































































































a  mixture was placed in a stainless steel syringe and melted at
120 °C in a high temperature cartridge unit, then plotted through
an 18-gauge needle by air pressure control using a 3D-Bioplotter
(4th Generation, Envisiontec). All samples were cut into 4 × 4 mm
scaffolds and sterilized using ethylene oxide at 42 °C for 3 h (EO
Gas sterilizer 5XL, 3 M). 
2.1.2. Determination of weight loss 
The pre-weighed scaffolds were individually immersed in 500
μL of phosphate buffered saline (PBS, 0.01 M, pH 7.4) solution
containing α-amylase (A6380, Sigma-Aldrich) at concentration of
145 U/L [26] . An experimental control of PBS was also performed.
All samples were incubated at 37 °C under constant shaking at
60 rpm for up to 90 days and all solutions were changed twice
a week. After each incubation period, a minimum of five samples
were removed from the solutions, rinsed in distilled water and let
to dry for 3 days at 37 °C. The weight loss was then determined. 
2.1.3. Magnetization analysis 
The magnetic properties of the magSPCL scaffolds were eval-
uated using a superconducting quantum interface device (SQUID-
SM) magnetometer from Quantum Design under a magnetic field
between −5 T ≤ B ≤ 5 T at room temperature (RT). 
2.1.4. Micro-Computed tomography analysis and scanning electron 
microscopy 
The morphology and structure of the magSPCL scaffolds were
analysed by high-resolution micro-CT with a Skyscan 1072 scan-
ner (Skyscan, Kontich, Belgium). The cross-section slices from ac-
quired micro-CT angular projections through the scaffolds were re-
constructed using the volumetric NRecon reconstruction (version
1.6.6.0, SkyScan) software. CT Vox micro-CT volume rendering soft-
ware (version 3.3.0) from Bruker was used to build 3D virtual
models of the scaffolds from acquired data sets with an origi-
nal/effective voxel size of 7.535 μm. 
Moreover, structure and morphology of the scaffolds was ana-
lyzed by scanning electron microscopy (SEM). After 7 days of cul-
ture, magSPCL constructs were rinsed in DPBS and fixed in 10% for-
malin (INOPAT) prior to dehydration and coated with gold. Images
were collected at an acceleration voltage of 10 kV (JSM-6010LV,
JEOL). 
2.2. Functionalization of MNPs and characterization 
2.2.1. Conjugation of MNPs 
Carboxyl functionalized magnetic nanoparticles (09-02-252, Mi-
cromod) were covalently bonded to Anti-Activin receptor type
IIA antibody (ab135634, Abcam) (MNPs-ActRIIA) by carbodiimide
chemistry as described previously [13] and detailed in the Supple-
mentary Materials and Methods. 
Functionalized MNPs (MNPs-ActRIIA) were diluted in H 2 O and
analyzed for surface charge and size using a Zetasizer Nano ZS
(Malvern Instruments) and NTA (NanoSight, NS, Malvern Instru-
ments) (Supplementary Results). The morphology of the particles
before (MNPs) and upon functionalization (MNPs-ActRIIA) were
observed by scanning electron microscopy (SEM) (Auriga Com-
pact, Zeiss) analysis. Drops of diluted suspensions were placed in
tissue culture coverslips (Sarstedt) and air dried overnight. Prior
to analysis, samples were sputter coated with gold, and images
were acquired at an acceleration voltage of 5 kV. The size, surface
charge, and morphology of MNPs-ActRIIA was compared to non-
functionalized commercial MNPs. 
2.2.2. Fourier transform infrared spectroscopy (FTIR) analysis 
The spectrum of the commercial carboxyl dextran MNPs and
of the functionalized MNPs (MNPs-ActRIIA) was obtained by FTIRpectroscopy in attenuated total reflectance mode (FTIR-ATR). For
hat, a drop of the sample was placed on the crystal. Spectra were
btained at transmittance mode in the range of 40 0 0–40 0 cm −1 
ith a resolution of 4 cm −1 . 
.2.3. Pierce BCA protein assay 
To estimate the binding efficiency of the antibody to the MNPs,
he supernatants of the particles solutions were collected during
he wash steps of the conjugation procedure and analysed by Mi-
ro bicinchoninic acid (BCA) assay (22,235, Thermo Fisher Scien-
ific), according to manufacturer’s instructions. Briefly, 150 μL of
amples and working reagent were mixed and incubated at 37 °C
or 2 h, and then the absorbance was read at 562 nm. The amount
f antibody conjugated to the MNPs was determined according to
he difference in protein concentrations between samples. Albumin
rotein standard solutions and a blank reading of 25 mM glycine
ere also analysed. 
.3. Cells isolation and expansion 
Human adipose stem cells (hASCs) were isolated from human
iposuction aspirates obtained from healthy females ( n = 3) with
n average age of 42 years, under informed consent, according
o the protocols previously approved by the Ethical Committee
f Hospital da Prelada (Porto, Portugal). The content of the writ-
en informed consent and related procedures were reviewed and
pproved by the Hospital Ethics Committee. hASCs were isolated
rom tissue samples and cultured as described before [27 , 28] , and
ave been previously characterized by RT-PCR for CD44, STRO-
, CD105 and CD90 markers, and also for multilineage potential
27 , 29] . Briefly, the tissue was rinsed in phosphate buffered saline
PBS, Sigma-Aldrich) containing 10% of an Antibiotic/Antimycotic
A/A) solution. The fat solution was immersed in a 0.05% collage-
ase type II (Sigma/ C6885) solution for 45 min at 37 °C under
ild agitation. The digested tissue was centrifuged at 800 g for
0 min at 4 °C, after which the supernatant was eliminated. Cells
ere expanded in basal medium composed of αMEM (120 0 0 063,
ife Technologies) supplemented with 10% FBS (15240062, Gibco)
nd 1% A/A solution (15240062, Gibco). For all experiments, cells
ere used at passage 2–4. Three independent experiments were
erformed, and samples were collected in triplicates. 
.3.1. Cells labeling with MNPs-ActRIIA and characterization 
hASCs were seeded at a density of 10 0,0 0 0 cells/well in 6-well
lates and incubated with MNPs-ActRIIA at 25 μg MNPs/2 × 10 5 
ells, for 30 min, in basal serum free medium. After the incuba-
ion period, cells were washed with Dulbecco’s phosphate-buffered
aline (DPBS) (ThermoFisher Scientific) to remove unbound MNPs. 
hASCs labeling was confirmed using Prussian Blue (PB) staining,
or iron detection, and SEM. For PB assay, cells were stained with a
olution of equal parts of 20% HCl (30721, Sigma-Aldrich) and 10%
otassium ferrocyanide (P3289, Sigma-Aldrich) for 30 min before
ashing 3 times with dH 2 O. Then, samples were visualized under
 transmitted and reflected light microscope (AxioVert A1 FL LED,
eiss). 
Prior to SEM observation (JSM-6010 LV, JEOL), specimens were
ehydrated and coated with gold, and images were collected at an
cceleration voltage of 10 kV. 
.4. Assessment of alternating magnetic field parameters effects on 
ASCs viability and proliferation 
In order to magnetically stimulate the tissue engineered con-
tructs, an alternating magnetic field (AMF) system was developed.
his custom designed device consists of a solenoid, in which an
lternating electrical current passes through a wire generating a



























































































































w  niform magnetic field inside the solenoid (Supplementary Figure
1). 
The AMF effect was investigated by varying the frequency
50 Hz or 100 Hz) to which hASCs were exposed [30] . The ef-
ect of AMF actuation in metabolic activity and cell content was
nvestigated at day 0 and day 7 of culture (Supplementary ma-
erial). The results suggest that the magnetic field resultant from
0 Hz frequency is promoting higher metabolic activity and cell
roliferation after 7 days in culture. Based on this, an AMF with
 frequency of 50 Hz and intensity of 1 mT, during 10 min, was
elected for the subsequent studies. Non-stimulated groups were
ept without magnetic field. 
.5. Phosphorylation assays of hASCs 
After hASCs labeling with MNPs-ActRIIA, samples were incu-
ated for 10 min in basal αMEM medium under AMF stimulation
 f = 50 Hz, B = 1 mT) or non-stimulated conditions. Cells cultured
ithout MNPs in αMEM medium supplemented with Recom-
inant Human/Mouse/Rat Activin A Protein (338-AC-010, R&D
ystems) were considered positive control of the receptor acti-
ation. The dose (20 ng/mL) and incubation period (10 min) of
ctivin A ligand were chosen based on literature and according
o the phospho-Smad2/Smad3 ELISA kit [13 , 31] . Also, to verify
he inhibition of the ActRIIA receptor and subsequent cascade of
hosphorylation, hASCs were treated for 24 h with the antagonist
B431542 (72232, Stem cell technologies) (10 μM). The TGF- β
uperfamily signal through a receptor complex comprising a type
I and type I receptor, both serine/threonine kinases. SB431542 is
mall-molecule inhibitor of type I activin receptor-like kinase-4,
5, −7 (ALK4/ALK5/ALK7), being a selective inhibitor of endoge-
ous activin and TGF- β signaling [32] . For the rescue experiments,
fter pre-treatment with SB431542, cells were incubated with
ctivin A ligand and MNPs-ActRIIA complex for 10 min in αMEM
edium under AMF stimulation or non-stimulated conditions. 
Then, the endogenous levels of phospho-Smad2 (Ser465/467)
nd phospho-Smad3 (Ser423/425) proteins were quantitatively as-
essed by ELISA assay (12001, Cell Signaling Technology), following
he manufacturer’s instructions. 
.6. Reactive Oxygen Species assay 
The oxidative stress of cells was analysed using a DCFDA - Cel-
ular Reactive Oxygen Species (ROS) Detection Assay (ab113851, Ab-
am). Briefly, hASCs were seeded at a density of 30,0 0 0 cells/well
n a dark clear bottom 96-well plate (Corning) and cultured
vernight in α-MEM medium. The following conditions were as-
essed: i) hASCs under non-stimulated conditions; ii) hASCs un-
er AMF stimulation; iii) hASCs in α-MEM medium supplemented
ith Activin A (20 ng/mL); iv) hASCs labelled with MNPs-ActRIIA
nder non-stimulated conditions; or v) hASCs labelled with MNPs-
ctRIIA under AMF stimulation. Cells were stained with DCFDA so-
ution for 45 min at 37 °C in the dark and, after that, the fluores-
ence was read with an excitation of 495/20 nm and an emission
f 529/20 nm using a microplate reader (Synergy HT, Bio-TeK In-
truments). After this, cells were incubated with TBHP for 4 h at
7 °C and the fluorescence was read. hASCs incubated only with
CFDA or incubated with DCFDA and TBHP represent the negative
nd positive controls, respectively. A blank reading without cells,
CFDA and TBHP was also performed. 
.7. Culture of hASCs on magSPCL scaffolds 
.7.1. Phosphorylation assay on magnetic constructs 
hASCs were seeded onto magSPCL scaffolds at a density of
65,0 0 0 cells/scaffold, left to adhere for 1h30 in α-MEM medium,nd then the following conditions were assessed: (i) hASCs un-
er non-stimulated conditions; (ii) hASCs under AMF stimula-
ion; (iii) hASCs in α-MEM medium supplemented with Activin
 (20 ng/mL); (iv) hASCs labelled with MNPs-ActRIIA under non-
timulated conditions; or (v) hASCs labelled with MNPs-ActRIIA
nder AMF stimulation. 
Prior analysis, the constructs were rinsed in ice cold DPBS,
craped in lysis buffer, and sonicated on ice for 10 min. After soni-
ation, the samples were centrifuged and the supernatant stored at
80 °C. The samples were further analysed by ELISA (PathScan R ©
hospho-Smad2 (Ser465/467)/Smad3 (Ser423/425), 12,001, Cell 
ignaling Technology). 
.7.2. Immunocytochemistry of pSmad2/3 
Cell-laden magSPCL scaffolds were cultured for up to 3 days
n basal medium, and AMF stimulation was provided at days 0
nd 3. Afterwards, the constructs were rinsed in DPBS and fixed
n 10% formalin (INOPAT) prior to the detection of pSmad2/3
#8828, Cell signaling technologies) deposition. After cell per-
eabilization with 0.1% Triton-X100 (Sigma/X100)/PBS solution, 
ll samples were blocked using RTU Normal Horse Serum (RTU
ectastain Kit, PK-7200, Vector) for 40 min at RT, to avoid non-
pecific reactions. Then, constructs were incubated overnight with
rimary antibody against pSmad2/3 diluted in antibody diluent
ith background reducing components (S3022, Dako) at 4 °C
nder gentle agitation. Afterwards, samples were rinsed in 0.1%
riton-X100 (Sigma/X100)/PBS solution followed by incubation for
 h at RT with Alexa fluor 488 secondary antibody (Alfagene).
inally, samples were stained with 4,6-Diamidino-2-phenyindole,
ilactate (DAPI, 5 μg/μL, D9564, Sigma) for 15 min. After washing,
he samples were kept in PBS at 4 °C until further visualization.
mmunolabelled samples were acquired by confocal laser scan-
ing microscopy (TCS SP8, Leica) and images analysed using LAX
oftware from Leica. 
To assess the co-localization of pSmad2/3 in the nucleus, ImageJ
o-localization measurement was performed to define the overlap
etween the blue channel (DAPI, nuclei) and the green channel
pSmad2/3 staining) ( n > 5). Then, area fraction measurement was
sed to determine the positively stained area. The values were nor-
alized by the total number of nuclei and shown as area of stain-
ng (pSmad2/3) per nuclei. 
.7.3. Long-term culture of hASCs on magSPCL scaffolds 
hASCs were seeded at a density of 65,0 0 0 cells/scaffold and
ultured for up to 21 days in α-MEM medium in the following
onditions: i) hASCs under non-stimulated conditions; ii) hASCs
nder AMF stimulation ( f = 50 Hz, B = 1 mT); iii) hASCs in
-MEM medium supplemented with Activin A (20 ng/mL); iv)
ASCs labelled with MNPs-ActRIIA under non-stimulated condi-
ions; or v) hASCs labelled with MNPs-ActRIIA under AMF stim-
lation ( f = 50 Hz, B = 1 mT). The constructs were further anal-
sed for cell morphology, metabolic activity, proliferation, and iron
elease by SEM, MTS assay, dsDNA quantification, and ICP, respec-
ively. Moreover, tendon associated markers were assessed by real
ime RT-PCR, quantification of collagen and non-collagenous pro-
eins, and immunocytochemistry. 
.7.3.1. Iron release measurement. The iron (Fe) released from the
agnetic constructs cultured for up to 21 days was evaluated by
CP-OES (Activa M, Horiba Jobin Yvon) using a Burguener MiraMist
ebulizer with 10 0 0 W power. The culture medium was collected
fter each time-point and frozen at −80 °C. α-MEM medium (10%
BS, 1% A/A) was used as blank solution for correction purposes.
amples were prepared by adding 250 μL of 69% HNO 3 (101799,
MSURE) to 500 μL of the samples and then diluted to 5% HNO 3 
ith ultra-pure H O. All samples were filtered with a 0.45 μm2 























































b  filter (VWR) prior analysis. An iron (Fe,10 0 0 μg mL −1 ) standard so-
lution (13830, Specpure) was used to prepare the diluted standard
solutions. 
2.7.3.2. MTS assay and DNA quantification. Metabolic activity of
hASCs cultured on magSPCL scaffolds was evaluated by MTS assay
(Cell Titer 96 Aqueous Solution Cell Proliferation Assay, Promega).
Briefly, after 7, 14 and 21 days of culture, the constructs were
transferred to another multiwell plate, washed with PBS and in-
cubated for 3 h at 37 °C and 5% CO 2 atmosphere in a mixture of
serum-free culture medium without phenol red and MTS solution
(5:1 ratio). Then, 100 μL of each sample was transferred to a 96
well-plate and the absorbance read at 490 nm (Synergy HT, Bio-
eK Instruments). The samples were read in triplicate and a blank
reading was also performed for correction purposes. 
The proliferation of hASCs was determined through DNA quan-
tification of cell lysates, using the Quant-iT TM PicoGreen R © dsDNA
kit (P7589, ThermoFisher), after 7, 14 and 21 days of culture. Sam-
ples were collected into microtubes with 1 mL of ultrapure water
and stored at −80 °C. Then, samples were thawed, sonicated, and
the supernatant analysed using a microplate reader with an excita-
tion of 485/20 nm and an emission of 528/20 nm (Synergy HT, Bio-
eK Instruments). Samples and standards were made in triplicate. 
2.7.3.3. Real time RT-PCR. Total RNA was extracted using TRI
reagent (T9424, Sigma) according to the manufacturer’s instruc-
tions. Briefly, 600 μL of TRI reagent was added to each sample
and stored at −80 °C. After defrosting, samples were incubated
with 160 μL of chloroform (Sigma) for 15 min and 12,0 0 0 g cen-
trifuged for 15 min at 4 °C. The aqueous fraction was collected andFig. 2. Characterization of magSPCL scaffolds. (A) Hysteresis loop of magSPCL scaffolds 
induction, B, is given in Tesla. (B) Degradation assay of magSPCL scaffolds in PBS and α-
showing different perspectives by micro-CT analysis (scale bar represents 500 μm). The p
white (Fe). (D) Representative SEM images of the magSPCL constructs after 7 days of cul
with statistical significant difference p < 0.05. (For interpretation of the references to colo00 μL of isopropanol (Sigma Aldrich) was added. After 10 min,
amples were centrifuged at 12,0 0 0 g for 10 min at 4 °C. RNA
ellet was washed with 800 μL of 70% ethanol and subsequently
entrifuged at 7500 g for 5 min at 4 °C. Air-dried RNA samples
ere resuspended in 15 μL of RNase/DNase free water (Gibco). RNA
uantity and purity were determined with a NanoDrop ND-10 0 0
pectrophotometer (NanoDrop Technologies). The cDNA synthesis
as performed with the qScript cDNA Synthesis kit (Quanta Bio-
ciences) and using the Mastercycler Realplex (Eppendorf) using an
nitial amount of total RNA of 1 μg in a total volume of 20 μL. The
uantification of the transcripts was carried out by quantitative
olymerase chain reaction (qPCR) using the PerfeCTA SYBR Green
astMix kit (Quanta Biosciences) following the manufacturer’s pro-
ocol, in a Real-Time Mastercycler Realplex thermocycler (Eppen-
orf). The primers were pre-designed with PerlPrimer v1.1.21 soft-
are (Supplementary Table S1) and synthesized by MWG Biotech.
CTB (actin beta) was used as the housekeeping gene. The 2 −Ct 
ethod was selected to evaluate the relative expression level for
ach target gene. All values were first normalized against ACTB
alues, and then to hASCs constructs cultured in basal α-MEM
edium for 3 days. 
.7.3.4. Quantification of collagen and non-collagenous proteins. The
mount of collagen and non-collagenous proteins deposited by
ASCs cultured on the magSPCL scaffolds was determined using
 semiquantitative assay, namely Sirius Red/Fast Green Collagen
taining Kit (9046, Chondrex). After day 7, day 14 and day 21 of
ulture, the constructs were fixed with 10% formalin and stored at
 °C until analysis. Briefly, the dye solution was added and incu-
ated for 40 min in order to completely immerse the fixed cells.under an applied magnetic field up to B = 5 T obtained by SQUID-VM. Magnetic 
amylase solutions, for up to 12 weeks. (C) 3D reconstructed images of the scaffold 
olymeric matrix is represented in blue (SPCL) and iron oxide MNPs are observed in 
ture with hASCs. Values represent the mean ± SD. Symbol ∗ denotes study groups 
r in this figure legend, the reader is referred to the web version of this article.) 







































 dye extraction buffer was then mixed and the OD values read in
 spectrophotometer (Synergy HT, Biotek Instruments) at 540 nm
nd 605 nm. 
.7.3.5. Immunocytochemistry. Cell-laden magSPCL scaffolds were
insed in DPBS and fixed in 10% formalin (INOPAT) prior to
he detection of Scleraxis (ab58655, Abcam) and Tenomodulin
ab81328, Abcam) deposition, according to the procedure described
bove for pSmad2/3 immunolocation. After that, the samples were
ept in PBS at 4 °C until further visualization. Immunolabelled
amples were acquired by confocal laser scanning microscopy
TCS SP8, Leica) and images processed using LAX software from
eica. 
Semi-quantification of immunocytochemistry was performed 
sing ImageJ by measuring the mean fluorescence intensity of mi-
roscopy images ( n > 5) acquired in different regions of the scaf-
old. Briefly, images were thresholded to separate the signal from
he background using Huang method [33 , 34] , and then the mean
uorescence values were determined and normalized by the total
ignal area. ig. 3. Functionalization and characterization of MNPs conjugated with anti-ActRIIA antib
ctRIIA and labeling of hASCs. (B) Analysis of conjugated MNPs by dynamic light scatte
onjugation method assessed by Micro-BCA assay and FTIR spectroscopy ( n = 3), Blue line
epresents the FTIR spectrum after functionalization (MNPs-ActRIIA). (D) SEM and Prussia.8. Statistical analysis 
Quantitative results are expressed as the mean ± standard de-
iation. Statistical analysis of data was performed using GraphPad
RISM version 6.01. The unpaired t-test was performed to compare
wo normal distributed populations. One-way analysis of variance
ANOVA) followed by the Tukey post hoc test for multiple com-
arisons or two-way analysis of variance (ANOVA) followed by the
olm–Sidak test for multiple comparisons was performed to com-
are groups of variables. Differences were considered significant
hen the p value was < 0.05. 
. Results and discussion 
.1. Production and characterization of magSPCL scaffolds 
Aligned fibrous magnetic scaffolds (magSPCL) were successfully
roduced by 3D-printing using a blend of starch and polycaprolac-
one incorporating iron oxide magnetic nanoparticles, as previously
eported by us [12] . ody (MNPs-ActRIIA). (A) Schematic illustration of MNPs functionalization with anti- 
ring (DLS) and scanning electron microscopy (SEM) ( n = 3). (C) Efficiency of the 
 represents the FTIR spectrum before functionalization (MNPs) and the orange line 
n Blue staining of MNPs-ActRIIA labelled hASCs ( n = 3). 





































s  The SQUID-VM analysis of the magSPCL scaffolds in which the
magnetization (M) as a function of the applied magnetic field
(B) (hysteresis loop) ( Fig. 2 A) revealed the absence of the coer-
cive forces and remanence magnetization at zero magnetic field.
This fact, confirms the superparamagnetic behavior of the mag-
netic scaffolds. Furthermore, a saturation magnetization (Ms) value
of 1.22 emu g −1 was determined, in the same range of values re-
ported for other developed magnetic scaffolds [11 , 12 , 35] . 
The material weight loss (%) was assessed by comparing the fi-
nal weight of the material after different periods (2, 4, 8 and 12
weeks) in degradation solutions, with the initial weight ( Fig. 2 B).
For samples immersed in PBS solution, a weight loss of 10.62% ±
1.03 was observed while in the presence of α-amylase, magSPCL
scaffolds present a weight loss of 12.2% ± 0.93 which demonstrates
that the presence of the enzyme increases the degradation rate
of the scaffolds. The same degradation behavior was observed in
previous studies for SPCL scaffolds [26 , 36 , 37] . Also, the solutions
collected during the degradation assay were analysed by ICP-OES
(Supplementary material), and the iron concentration was found to
be below 50 μg L −1 in all the degradation solutions (quantification
limit of the method 50 μg L −1 ). Fig. 4. Phosphorylation assessment of Smad2/3 in hASCs. (A) Schematic representation 
cation of pSmad2/3 by ELISA assay in (B1) hASCs cultured in αMEM medium supplemen
and non-stimulated, hASCs labelled with MNPs-ActRIIA cultured in αMEM medium under
conditions as in B1 after 24 h pre-incubation with SB431542 antagonist of type I activ
scaffolds under non-stimulated and AMF stimulation conditions. (D1) Assessment of pSm
same conditions of B1, after 3 days of culture (scale bar represents 50 μm), and the res
software (D2). Three independent experiments were performed ( n = 3). Values represen
significant difference p < 0.05, p < 0.01, p < 0.001 and p < 0.0 0 01, respectively. The alignment of the fibers and the effectiveness of MNPs in-
orporation in the 3D structure was confirmed by micro-CT analy-
is ( Fig. 2 C), showing the parallel alignment of the polymeric fibers
nd the presence of MNPs homogeneously distributed in the fiber
etwork. Moreover, fiber diameter measurements (657.4 8 ± 4 9.4 8)
m were assessed by microscopy images acquired in different re-
ions of the scaffold ( n > 10). 
In Fig. 2 D, representative SEM images of the magSPCL con-
tructs after 7 days of culture further support the microarchitec-
ural alignment of the scaffolds, showing the fibers alignment,
rooves distribution, and cellular bridging between fibers. 
.2. Development and characterization of functionalized MNPs 
After functionalization of MNPs with anti-ActRIIA antibody by
arbodiimide chemistry ( Fig. 3 A), the size and surface charge of
NPs and MNPs-ActRIIA were determined by DLS ( Fig. 3 B) and
TA (Supplementary Figure S2). Results show that the particles
ize increased after anti-ActRIIA conjugation which confirms the
unctionalization of the MNPs with the antibody. Furthermore, the
urface charge increased in MNPs-ActRIIA suggesting an improvedof the downstream phosphorylation of Smad2/3 upon ActRIIA activation. Quantifi- 
ted with Activin A (positive control), hASCs cultured in αMEM medium untreated 
 non-stimulated and AMF stimulation conditions; (B2) hASCs cultured in the same 
in receptor-like kinase. (C) hASCs labelled with MNPs-ActRIIA laden on magSPCL 
ad2/3 immunolocation by immunocytochemistry in magSPCL constructs under the 
pective semi-quantification of nuclear co-localization of the pSmad2/3, by ImageJ 
t the mean ± SD. Symbol ∗ , ∗∗ , ∗∗∗ and ∗∗∗∗ denotes study groups with statistical 
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Fig. 5. (A) Metabolic activity by MTS assay, and (B) proliferation assessment by dsDNA quantification assay, of hASCs cultured in αMEM medium supplemented with 
Activin A, hASCs cultured in αMEM medium under non-stimulated and AMF stimulation conditions and hASCs labelled with MNPs-ActRIIA cultured in αMEM medium 
under non-stimulated and AMF stimulation conditions, after 7, 14 and 21 days of culture in magSPCL scaffolds. (C) ROS quantification in hASCs cultured in αMEM medium 
supplemented with Activin A (20 ng/mL), hASCs cultured in αMEM medium under non-stimulated and AMF stimulation conditions and hASCs labelled with MNPs-ActRIIA 
cultured in αMEM medium under non-stimulated and AMF stimulation conditions, estimated according to the DCFDA assay. (D) Quantification of iron released from magSPCL 
to the medium collected during 21 days, by ICP-OES analysis. Three independent experiments were performed ( n = 3). Values represent the mean ± SD. Symbol ∗ , ∗∗ and 





















































medium were incubated with Activin A or MNPs-ActRIIA under abeling effect of the conjugated MNPs with the negatively charged
ell membrane. The morphology of the MNPs and MNPs-ActRIIA
as analysed by SEM ( Fig. 3 B) showing the expected round shape
f the particles. Also, particle aggregates are diminished on sam-
les upon functionalization with antibody. 
FTIR spectrum ( Fig. 3 C) of the MNPs (blue) exhibits the char-
cteristic peak of carbonyl stretch C = O of the carboxylic acids
t 1619 cm −1 . The MNPs-ActRIIA spectrum (orange) exhibits two
ands characteristic of the amide group, amide I band around
634 cm −1 (C = O stretch) and amide II band (N –H bend) around
539 cm −1 . The replacement of the carboxylic acid group band
y two amide group bands strongly suggests that the conjugation
etween the MNPs and the anti-ActRIIA antibody by EDAC/NHS
hemistry was successful. 
The efficiency of MNPs conjugation was determined using
he BCA protein assay by estimating the amount of anti-ActRIIA
onjugated to MNPs ( Fig. 3 C). During the conjugation procedure,
he supernatant was collected before and after incubation with
he activated MNPs for further protein content measurement. The
rotein present on the supernatants solutions decreased and a
inding efficiency of (37 ± 13)% was obtained, which is in good
greement with values found in literature [38] . 
The labeling of hASCs with MNPs-ActRIIA was confirmed by
EM analysis and Prussian Blue (PB) staining ( Fig. 3 D) in which
t is possible to observe the conjugated MNPs in white (SEM) or
lue (PB) targeting the cell membrane after 30 min of labeling
eriod. .3. Assessment of Smad 2/3 phosphorylation in hASCs triggered by 
ctivin A or MNPs-ActRIIA 
The binding of TGF- β family ligands to cell membrane recep-
ors, such as ActRIIA, induces phosphorylation and activation of the
eceptor initiating an intracellular signaling that leads to the phos-
horylation of Smad proteins [39] . Thus, the activation of the Ac-
RIIA was indirectly assessed through detection of the downstream
hosphorylation of Smad2/3 proteins ( Fig. 4 A). 
The capability of functionalized MNPs to remotely target and
ctivate the ActRIIA receptor via magnetic mechano stimulation
as investigated using AMF stimulation ( Fig. 4 B1). The higher
hosphorylation of Smad2/3 in hASCs labelled with MNPs-ActRIIA
nder AMF stimulation suggested that ActRIIA is a mechanosensi-
ive receptor that can be activated using MNPs-ActRIIA, which was
lso verified elsewhere, however using a different magnetic device
13] . The actuation of an external AMF causes vibrations of the
NPs-Ab complex enhancing mechano activation of the receptor
13 , 18 , 19] . 
In the inhibition experiments, hASCs were treated with
B431542, an exogenous antagonist against the activin receptor
nd, consequently, reported to inhibit the TGF- β/Smad2/3 signal-
ng [32 , 40] . After confirming the involvement of the antagonist in
he inhibition of the receptor, a rescue experiment was performed
o insight on the reactivation of the phosphorylation cascade by
he ligands. Thus, pre-treated hASCs with SB431542 supplemented
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Fig. 6. Real time RT-PCR analysis of (A) tenogenic markers scleraxis (SCX), tenomodulin (TNMD), tenascin-C (TNC), decorin (DCN), collagen type I (COL1A1), and (B) bone 
morphogenetic protein 2 (BMP2), chondrogenic markers SOX9 and aggrecan (ACAN), and adipogenic marker peroxisome proliferator-activated receptor gamma (PPAR- ϒ), 
of hASCs cultured in (i) αMEM medium supplemented with Activin A, (ii) hASCs cultured in αMEM medium under non-stimulated and (iii) AMF stimulation conditions 
and (iv) hASCs labelled with MNPs-ActRIIA cultured in αMEM medium under non-stimulated and (v) AMF stimulation conditions, after 7, 14 and 21 days of culture on 
magSPCL scaffolds. Three independent experiments were performed ( n = 3). Values represent the mean ± SD. Symbol ∗ , ∗∗ , ∗∗∗ and ∗∗∗∗ denotes study groups with statistical 















non-stimulated or AMF stimulation conditions ( Fig. 4 B2). The
phosphorylation values of cells treated with Activin A or hASCs
untreated were significantly different ( p < 0.05) than the values of
all samples that were pre-exposed to the antagonist. Overall, the
results showed that hASCs treatment with SB431542 was able to
inhibit the receptor and subsequent Smad2/3 pathway which is in
agreement with Inman GJ et al. that demonstrated that inhibitionf the activin receptors with SB431542 and the subsequent treat-
ent with TGF- β and Activin ligands does not rescue pSmad2 in
eratinocytes, fibroblasts, and myoblasts cell lines [32] . 
In magSPCL constructs, there is a higher phosphorylation ten-
ency of the protein complex in hASCs labelled with MNPs-ActRIIA
nder actuation of AMF ( p > 0.05), what may suggest a more effi-
ient activation of the ActRIIA receptor ( Fig. 4 C). 
A.M. Matos, A.I. Gonçalves and M.T. Rodrigues et al. / Acta Biomaterialia 113 (2020) 488–500 497 
Fig. 7. Quantification of collagen and non-collagenous proteins by Sirius Red/Fast Green Collagen staining kit in (i) hASCs cultured in αMEM medium supplemented with 
Activin A, (ii) hASCs cultured in αMEM medium under non-stimulated and (iii) AMF stimulation conditions and (iv) hASCs labelled with MNPs-ActRIIA cultured in αMEM 
medium under non-stimulated and (v) AMF stimulation conditions after 7, 14 and 21 days of culture on magSPCL scaffolds. Three independent experiments were performed 









































































o  The activation of the ActRIIA induces phosphorylation of the
mad2/3 proteins that translocate to the nucleus regulating the
xpression of target genes [41] . In our study, the immunolocation
f pSmad2/3 is more easily observed in the nucleus on hASCs la-
elled with MNPs-ActRIIA seeded on magSPCL scaffolds under AMF
timulation conditions, which also confirms that the actuation of
MF on MNPs-ActRIIA enhances the activation of the receptor via
agnetic mechano actuation ( Fig. 4 D1, D2). These findings sug-
est that the actuation of a magnetic field on a magnetic scaf-
old induces local substrate deflections creating transient physi-
al forces sensed by the cultured cells in close proximity to the
anoparticles which promotes mechanotransduction mechanisms 
5 , 11] , possibly driving differentiation of stem cells. This also sup-
orts the obtained very weak pSmad2/3 signals in the nuclei of
nlabeled hASCs laden on magnetic scaffolds. On the other hand,
he MNPs tagged hASCs stimulated by an AMF will sense transla-
ional forces directed along the magnetic field inducing the mo-
ion of MNPs attached via membrane receptors, ultimately activat-
ng mechanotransduction processes [7] . It has been also reported
hat less than 0.2 pN was required to activate the TREK-1 channel
6] , and the estimated magnetically induced mechanical force im-
arted on cells grown on alginate magnetic scaffolds was reported
n the order of 1 pN [5] to induce mechanoresponsive effects at
he cellular level. 
Although the precise constructs deformation upon magnetic
timulation was not investigated in the present work, we hypoth-
size that the total forces applied in our constructs as a result-
ng combination of actuable magSPCL and MNPs-ActRIIA labelled
ASCs leads to a more pronounced tenogenic response. However,
orthcoming work is needed to overcome this limitation. 
.4. hASCs metabolic activity, proliferation, oxidative stress, and iron 
elease 
The metabolic activity and cell proliferation of hASCs were
ssessed by MTS assay and dsDNA quantification, respectively
 Fig. 5 A and Fig. 5 B). The results showed an increase in both
etabolic activity and cell proliferation after 21 days in cultureuggesting that the external AMF applied to the 3D constructs did
ot affect negatively the cell behavior. 
Reactive oxygen species (ROS) regulate cell homeostasis and
ay accumulate in response to environmental stress disrupting
ormal cellular processes [42] . The role of the magnetic field in
xidative stress is controversial, however, ROS assay was performed
o study the effect of AMF stimulation on hASCs response ( Fig. 5 C).
ur results showed no difference between samples under AMF
timulation and non-stimulated conditions, suggesting that envi-
onmental stress produced by the actuation of the AMF is not dele-
erious for hASCs. 
Furthermore, in order to evaluate the possible release of MNPs
rom the magnetic scaffolds, the medium collected during the
ell culture assay was analysed for elemental iron by ICP- OES
 Fig. 5 D). All values of iron concentration were normalized in
elation to α-MEM medium (supplemented with 10% FBS and 1%
/A) that presents an iron concentration of 290 ± 0.01 μg L −1 .
he overall release of iron from magSPCL scaffolds (without cells)
nto the culture medium was higher in the presence of an external
MF in comparison with non-stimulated conditions. The actuation
f a magnetic field on the 3D constructs is expected to cause mi-
or vibrations of the MNPs incorporated in the scaffold structure
5] and, consequently, this might promote to some extent, particles
elease from the fibers, which explains the increase of iron release
nder AMF stimulation. This also corroborates with previously
eported data of our group [12] . Moreover, the release of iron to
he medium was higher in cell-free samples in comparison with
ells laden scaffolds, at all time-points. This suggests that the iron
ontribution to the culture medium derives from the scaffold’s
mbedded MNPs and not from MNPs-ActRIIA labelled hASCs. 
.5. Gene expression 
The effect of an externally applied AMF was investigated over
he 21 days culture period in the tenogenic commitment of hASCs.
eal time reverse transcription polymerase chain reaction (RT-PCR)
as performed at day 7, 14 and 21, particularly focusing on a panel
f tendon related markers including SCX, TNMD, DCN, TNC, and
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Fig. 8. Immunocytochemistry of Tenomodulin (TNMD) and Scleraxis (SCX) (green) deposited by hASCs laden on magSPCL and cultured in (i) αMEM medium supplemented 
with Activin A, (ii) hASCs cultured in αMEM medium under non-stimulated and (iii) AMF stimulation conditions, and (iv) hASCs labelled with MNPs-ActRIIA cultured in 
αMEM medium under non-stimulated and (v) AMF stimulation conditions, assessed after 7 and 21 days of culture. DAPI (blue) stains cell nuclei. Inset image represent the 
brightfield channel which enables to identify the fibers of the scaffold in dark color and the space between fibers in white. Scale bars represent 250 μm. B) Normalized 
mean fluorescence intensity semi-quantification of TNMD and SCX, respectively, analysed by ImageJ software. Three independent experiments were performed ( n = 3). 
Values represent the mean ± SD. Symbol ∗ and ∗∗ denotes study groups with statistical significant difference p < 0.05 and p < 0.01, respectively. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of this article.) 
























































































































OL1A1 ( Fig. 6 A). The expression of SCX and TNMD was higher in
MF stimulation conditions at 14 days ( p < 0.05). Magnetic field
ctuating on hASCs laden on magnetic fibrous scaffolds was shown
o activate the transcriptional factors YAP and TAZ [11] , which
pon activation are translocated to the nucleus, promoting stem
ell differentiation. It was verified by Tomás AR et al. an increase
n nuclear YAP/TAZ, indicative of tension of the cytoskeleton which
as likely caused by its adjustment to the external physical stimu-
us [11 , 43] . This mechanotransduction mechanism was suggested
o boost hASCs tenogenic differentiation [11] , further supporting
ur results. Similarly, in our study, the more effective activation
f TGF- β/Smad2/3 mechanism under AMF actuation, triggered the
xpression of target genes. After 21 days in culture, the expression
f these genes was higher on hASCs labelled with MNPs-ActRIIA
eeded on magSPCL scaffolds under AMF stimulation. Beyond mag-
etically actuated magSPCL potential per se in mediating external
timulus and cellular responses, these results also suggest that di-
ectly targeting the ActRIIA receptor by magnetic mechano activa-
ion, enhanced the upregulation of tendon related genes. 
On the other hand, the overall expression of non-tendon related
arkers tended to be downregulated in all conditions and time-
oints ( Fig. 6 B). Particularly from day 7 to 21, the expression of
MP2 , an osteogenic marker [44] , significantly decreased in AMF
timulated hASCs-MNPs-ActRIIA cultured in magSPCL ( p < 0.01).
he chondrogenic markers SOX9 [45] and ACAN expressions were
lso downregulated throughout the time in all conditions. More-
ver, and despite of the adipose tissue source of stem cells used
n this study, the expression of the adipogenic-related gene PPAR-
was downregulated throughout the time course of the experi-
ent. PPAR- ϒ expression after 14 and 21 days was lower in AMF
timulated hASCs labelled with MNPs-ActRIIA seeded on magSPCL
caffolds ( Fig. 6 B). Taken together, these results suggest that the
enogenic commitment of hASCs was enhanced by the synergy be-
ween remote magnetic actuation via MNPs-ActRIIA and via 3D
agSPCL scaffolds, in regulating the tenogenic phenotype of hASCs
hile decreasing the expression of genes related to other lineages.
.6. Extracellular matrix formation (ECM) 
The amount of collagen and non-collagenous proteins produced
y hASCs labelled with MNPs-ActRIIA seeded on magSPCL scaffolds
nder AMF stimulation tended to increase from day 7 to 21 days
n culture ( Fig. 7 ). At day 7, there is greater collagen production
n hASCs constructs compared to all other groups. Moreover, at
ay 21 there is no difference in collagen production between non-
timulated and AMF stimulated groups. Contrariwise, it is possible
o observe that the production of non-collagenous proteins after
1 days by hASCs labelled with MNPs-ActRIIA seeded on magSPCL
caffolds under AMF stimulation is significantly higher compared
o non-labelled hASCs either AMF stimulated ( p < 0.001) or not
 p < 0.05). Interestingly, MNPs-ActRIIA labelled cells produce more
on-collagenous proteins ( p < 0.001) in static scaffolds than plain
ells AMF stimulated, suggesting a key role in triggered ActRIIA cell
eceptors. 
The tenogenic commitment of hASCs was also evaluated by
tudying the deposition of two of the most widely accepted
enogenic markers, SCX and TNMD [46] , by immunocytochemistry
 Fig. 8 A) after 7 and 21 days. At both time-points, TNMD depo-
ition tended to enhance in hASCs labelled with MNPs-ActRIIA
aden on magSPCL scaffolds under AMF stimulation ( Fig. 8 B). On
he other hand, the expression of SCX was significantly higher on
ASCs labelled with MNPs-ActRIIA in comparison with the condi-
ions comprising unlabeled cells at day 7 ( Fig. 8 B), and no differ-
nces were observed at day 21 for SCX. Comparing MNPs-ActRIIA
agged hASCs under non-stimulated or AMF stimulation conditions,
he actuation of a magnetic field increased SCX production at therotein level. A higher level of SCX was observed in the condition
ith MNPs-ActRIIA under AMF stimulation at both time-points.
owever, we observe a decrease tendency from 7 to 21 days. The
ranscription factor SCX is mainly expressed during early tendon
evelopment thus regulating tissue formation [2 , 46] . Also, the fact
hat the production of SCX at day 7 by hASCs labelled with MNPs-
ctRIIA seeded on magSPCL scaffolds under AMF stimulation is
igher, and the increased TNMD deposition at day 21 in the same
ondition is in agreement with the role of SCX as a transcriptional
nducer of TNMD [22 , 47] . 
. Conclusions 
The technology of remote activation of mechanotransduction
ia magnetic nanoparticles (MNPs) has been broadly employed to
rigger different cellular receptors or ion channels. In the present
tudy, we have successfully used this approach in a 3D envi-
onment comprising magnetic scaffolds laden with MNPs-ActRIIA
agged hASCs and exposed to the actuation of an externally applied
lternating magnetic field. Remote magnetic actuation of MNPs-
ctRIIA complex t agging the mechanosensitive ActRIIA receptor
f hASCs was able to activate the TGF- β signaling pathway via
mad2/3 cascade both in 2D and 3D cultures, as shown by phos-
horylation of Smad2/3 proteins and their nuclear co-localization.
lso, the synergistic effect of the magnetically responsive scaf-
olds and MNPs-ActRIIA tagged hASCs boosted the commitment of
ASCs into the tenogenic lineage. 
The potential application of this engineered magnetically-
esponsive system in vivo may provide a new platform to commit
ASCs towards tenogenesis by modulating the TGF- β/Smad2/3 sig-
aling pathway involved in tendon repair and improving the po-
ential of TE strategies in the effective regeneration of functional
endon tissue. 
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